Moderate

Chronic hyponatraemia — ambulatory evaluation

chronic hypoNa · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Structured outpatient work-up of persistent mild-to-moderate hyponatraemia using volume status, serum and urine osmolality and urine sodium to classify the cause, most often SIADH, diuretics or hypovolaemia. Correction is cause-directed and deliberately slow to avoid osmotic demyelination.

Red flags

  • Acute severe symptoms (seizures, reduced consciousness) — needs emergency hypertonic saline
  • Sodium <120 mmol/L or rapidly falling
  • New neurological signs suggesting a CNS cause
  • Features of malignancy (weight loss, haemoptysis)
  • Overcorrection risk (high-risk: malnutrition, alcohol, hypokalaemia, liver disease)

Assessment

Differential diagnosis

  • SIADH (drugs, malignancy, pulmonary/CNS disease)
  • Thiazide-induced hyponatraemia
  • Hypovolaemic hyponatraemia (GI/renal losses)
  • Hypervolaemic (heart failure, cirrhosis, nephrotic)
  • Hypothyroidism / adrenal insufficiency
  • Primary polydipsia / low solute (beer potomania, tea-and-toast)

Investigations

  • Serum sodium, osmolality, glucose and potassium
  • Urine osmolality and urine sodium (key classifiers)
  • Volume status assessment (clinical)
  • TSH and 9am cortisol (exclude hypothyroid/adrenal)
  • Renal/liver function and medication review (thiazides, SSRIs, carbamazepine)
  • Consider chest imaging/CT if SIADH from occult malignancy suspected

Management

  • Confirm true hypotonic hyponatraemia: check serum osmolality and exclude hyperglycaemia/pseudohyponatraemia
  • Assess clinical volume status (hypovolaemic, euvolaemic, hypervolaemic)
  • Measure urine osmolality and urine sodium to categorise the cause
  • Review medications — stop thiazides, and reassess SSRIs/SNRIs, carbamazepine and other culprits
  • Exclude endocrine causes: hypothyroidism and adrenal insufficiency (cortisol)
  • Diagnose SIADH when euvolaemic with concentrated urine (osm >100), urine Na >30, normal thyroid/adrenal function and no diuretics
  • Treat hypovolaemic cases with isotonic saline and correct losses
  • Treat hypervolaemic cases (heart failure, cirrhosis) with fluid/sodium restriction and the underlying disease
  • Manage SIADH with fluid restriction first-line; add oral urea or a loop diuretic +/- salt if inadequate
  • Search for an underlying SIADH cause (CNS, pulmonary, malignancy, drugs)
  • Correct sodium slowly: limit rise to <8-10 mmol/L in 24 h (<6-8 if high risk) to avoid osmotic demyelination
  • Arrange interval monitoring of sodium and address the underlying disorder

Drugs & doses

Fluid restriction 800-1000 mL/day (first-line for SIADH)
Oral urea 15-30 g PO daily (SIADH refractory to fluid restriction)
Furosemide 20-40 mg PO daily with sodium chloride supplementation (SIADH with high urine osmolality)
Sodium chloride (salt) tablets as adjunct to raise solute load
Tolvaptan 15 mg PO daily (selected refractory SIADH; specialist, monitor sodium closely)
Hydrocortisone replacement if adrenal insufficiency confirmed

Disposition

Outpatient evaluation; endocrine/nephrology referral for refractory or diagnostically unclear cases. Emergency care for acute severe symptomatic hyponatraemia.

Complications & pitfalls

  • Osmotic demyelination syndrome from overcorrection
  • Falls and cognitive impairment
  • Fractures (chronic hyponatraemia weakens bone)
  • Underlying malignancy if missed
  • Recurrent symptomatic hyponatraemia

Exam pearls

  • Urine osmolality and urine sodium are the two key discriminators
  • Always exclude hypothyroidism and adrenal insufficiency before labelling SIADH
  • Thiazides are a very common and reversible cause
  • Correct chronic hyponatraemia slowly — demyelination risk, not the number, drives harm
  • Beer potomania/low-solute diets cause dilute urine and respond to solute, not just restriction

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.